Profile picture

Mr Maximilian Mueller

Charité - University Medicine Berlin, Berlin (Germany)
Follow
Logo ESC

Contributor content

Bioactive adrenomedullin as a predictor of clinical outcomes in cardiac transthyretin amyloidosis
Presentation
Bioactive adrenomedullin as a predictor of clinical outcomes in cardiac transthyretin amyloidosis
See more
Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis
Presentation
Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources